Researchers found significant differences in ovarian cancer survival among Asian American subgroups, emphasizing the ...

Ovarian cancer vaccines are under development, but none are ready for primetime. There are no screening tools for ovarian ...

The Fussell family has been committed to changing the future of ovarian cancer, ever since hearing Professor Anna deFazio AM ...

"I feel like I have a responsibility to scream and shout loudly about it and say 'hey, this is killing women in Australia'," ...

The Wistar Institute's Nan Zhang, Ph.D., assistant professor in the Ellen and Ronald Caplan Cancer Center's Molecular and ...

The following is a summary of “CD1a affects the recurrence and prognosis of ovarian cancer,” published in the November 2024 ...

FDA Project Team supports the company’s proposed Phase 3 trial strategy, including overall trial design, target patient population, treatment ...

“Our work has opened the door to a possible new method of treating a particularly aggressive cancer,” said Brennah Murphy, Ph.D., first author of the paper. “Ovarian cancer is infamous for resisting ...

It induces a specific type of immunity, called Th17 immunity, that seems to prevent suppression of the immune system. The ...

and lab have discovered a new approach to treating ovarian cancer that, in preclinical laboratory testing, shrinks tumors and improves survival rates while simultaneously making tumors more receptive ...

A breakthrough AI-powered liquid biopsy combining cell-free DNA and protein biomarkers improves early detection of ovarian ...

AbbVie receives European marketing approval for Elahere for the treatment of platinum-resistant ovarian cancer: North Chicago, Illinois Tuesday, November 19, 2024, 10:00 Hrs [IST] ...